Literature DB >> 20736849

Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme.

Jennifer R Madden1, Steven O Addo-Yobo, Andrew M Donson, Arthur K Liu, Sean A McNatt, B K Kleinschmidt-Demasters, Laura Z Fenton, Nicholas K Foreman, Amy A Smith.   

Abstract

Outcomes for average-risk medulloblastoma are excellent with 5-year event-free survival and overall survival>80%. Treatment failures include radiation-induced glioblastomas (RIG), which are often diagnosed solely on imaging. Recent studies suggest that RIGs differ from spontaneous glioblastoma multiforme (GBM), based on microarray gene-expression profiling. Retrospective review of children with average-risk medulloblastoma treated from 1996 to 2003 included 16 patients with 5 treatment failures. One died of disease progression, 1 died as a result of radiation necrosis, and 3 children died of pathology-confirmed GBM. Of these 3 GBMs, one was studied with electron microscopy, cytogenetics, and gene-expression microarray analysis. This tumor had focal medulloblastoma and similarity by gene-expression microarray with other RIGs. With both components in the recurrent tumor, we suggest it was in the process of transitioning from medulloblastoma to RIG, that is, "catching the tumor in the act." Some radiation-induced nervous system tumors may develop as a direct result of severe oncologic changes within the original tumor cells, with the tumor evolving into a different phenotypic tumor type. We recommend biopsy for tissue confirmation and genetic expression profile to shed light on the etiology of radiation-induced neoplasms.

Entities:  

Mesh:

Year:  2010        PMID: 20736849     DOI: 10.1097/MPH.0b013e3181e51403

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

Review 1.  The Pathophysiology of Post-Traumatic Glioma.

Authors:  Donata Simińska; Klaudyna Kojder; Dariusz Jeżewski; Ireneusz Kojder; Marta Skórka; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2018-08-19       Impact factor: 5.923

Review 2.  Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.

Authors:  Han Zou; Brad Poore; Alberto Broniscer; Ian F Pollack; Baoli Hu
Journal:  Cancers (Basel)       Date:  2020-03-10       Impact factor: 6.639

Review 3.  Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis.

Authors:  Jacqueline P Whitehouse; Meegan Howlett; Aniello Federico; Marcel Kool; Raelene Endersby; Nicholas G Gottardo
Journal:  Neurooncol Adv       Date:  2021-08-12

4.  Glioblastoma Following Treated Medulloblastoma After 29 Years in the Posterior Fossa: Case Report and Review of Literature.

Authors:  Tarek Mesbahi; Hind Zaine; Ismaël Mahazou Abdou; Tarik Chekrine; Souha Sahraoui; Mehdi Karkouri; Abdelhakim Lakhdar
Journal:  Front Oncol       Date:  2022-04-13       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.